DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Tech
Author Program NEWCreate Narrative
MIR logo

Mirion Technologies, Inc. Stock Price

NYSE:MIR Community·US$3.8b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

MIR Share Price Performance

US$15.51
-5.10 (-24.75%)
​
US$24.80
Fair Value
US$15.51
-5.10 (-24.75%)
37.5% undervalued intrinsic discount
US$24.80
Fair Value
Price US$15.51
AnalystConsensusTarget US$24.80
Thu, 30 Jul 26
Fair ValueUS$24.80
Share Pricen/a

MIR Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$24.8 37.5% undervalued intrinsic discount

MIR: Expect Opportunities As New Partnerships And Index Inclusions Shape Outlook

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
MIR logo
Mirion Technologies
37.5% undervalued intrinsic discount

MIR: Expect Opportunities As New Partnerships And Index Inclusions Shape Outlook

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 30 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
MIR logo

MIR: Index Additions And 2026 Guidance Will Support Future Upside

Fair Value: US$24.8 37.5% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Proven track record with moderate growth potential.

3 Risks
4 Rewards
View Full Analysis

Mirion Technologies, Inc. Key Details

US$1.0b

Revenue

US$530.9m

Cost of Revenue

US$494.0m

Gross Profit

US$469.5m

Other Expenses

US$24.5m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.10
48.20%
2.39%
64.1%
View Full Analysis

About MIR

Founded
2005
Employees
3281
CEO
Thomas Logan
WebsiteView website
www.mirion.com

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Recent MIR News & Updates

Seeking Alpha • Aug 13

Mirion: Nuclear Orders Are Surging, But Revenue Must Catch Up

Summary Mirion Technologies is positioned for nuclear sector growth, with a backlog above $1.1 billion and recent acquisitions enhancing capabilities. Despite a strong order book, Q2 organic growth was only 1%, and the current valuation requires faith in a sharp second-half acceleration. MIR trades at 28x 2026E EPS, with ambitious targets for margin expansion and organic growth already priced in. I rate MIR a Hold, as the stock lacks sufficient margin of safety until operational inflection is reflected in reported numbers. Read the full article on Seeking Alpha

Recent updates

No updates

Mirion Technologies, Inc. Competitors

SNX logo

TD SYNNEX

Symbol: NYSE:SNX
Market cap: US$20.2b
CDW logo

CDW

Symbol: NasdaqGS:CDW
Market cap: US$19.0b
ZBRA logo

Zebra Technologies

Symbol: NasdaqGS:ZBRA
Market cap: US$16.7b
FN logo

Fabrinet

Symbol: NYSE:FN
Market cap: US$14.8b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide